President Bola Tinubu has congratulated the National Agency for Food and Drug Administration and Control (NAFDAC) for maintaining the World Health Organisation’s (WHO) Maturity Level 3 (ML3) status for the regulation of medicines and vaccines.
According to a statement issued today by the Special Adviser to the President on Information and Strategy, Bayo Onanuga, the endorsement follows a re-benchmarking exercise conducted by the WHO from May 28 to 30, 2025, assessing NAFDAC against global standards for regulatory performance.
NAFDAC first attained ML3 status in 2022, becoming the first National Regulatory Authority in Africa to achieve the milestone for regulating medicines and vaccines (non-producing).
Welcoming the WHO’s verdict, which affirmed that NAFDAC operates “a stable, well-functioning, and integrated framework for regulating medicines and vaccines (non-producing),” President Tinubu commended the agency’s management and staff for their professionalism, consistency, and dedication to safeguarding public health.